| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2022 | Nov 14, 2022 | Roivant Sciences Ltd. | 10% Owner | Buy | 95.0 | +4,000,000 | 4.05% | ✗ | $20M |
| Apr 22, 2022 | Apr 26, 2022 | Roivant Sciences Ltd. | 10% Owner | Buy | 52.5 | +40,285 | 0.04% | ✗ | $155K |
| Jun 2, 2021 | Jun 3, 2021 | Protalix BioTherapeutics, Inc. | 10% Owner | Sell | 17.5 | -918,717 | -20.16% | ✗ | $2.1M |